These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22967780)

  • 1. Does varenicline worsen psychiatric symptoms in patients with schizophrenia or schizoaffective disorder? A review of published studies.
    Cerimele JM; Durango A
    J Clin Psychiatry; 2012 Aug; 73(8):e1039-47. PubMed ID: 22967780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.
    Williams JM; Anthenelli RM; Morris CD; Treadow J; Thompson JR; Yunis C; George TP
    J Clin Psychiatry; 2012 May; 73(5):654-60. PubMed ID: 22697191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varenicline precipitating psychosis in a patient with no previous psychiatric history: a case report of a Spanish patient who was later diagnosed with paranoid personality disorder.
    Forcen FE; Martinez FL; Moya AM
    Clin Schizophr Relat Psychoses; 2012 Jan; 5(4):221-3. PubMed ID: 22182460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Worsening psychosis induced by varenicline in a hospitalized psychiatric patient.
    DiPaula BA; Thomas MD
    Pharmacotherapy; 2009 Jul; 29(7):852-7. PubMed ID: 19558259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varenicline: aggression and homicidal ideation.
    Prescrire Int; 2012 Feb; 21(124):42-3. PubMed ID: 22413719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varenicline induced polydipsia and hyponatremia in a patient with schizophrenia.
    Ismail Z; Syms J; Blumberger D; George TP
    Schizophr Res; 2010 Jun; 119(1-3):268. PubMed ID: 20178890
    [No Abstract]   [Full Text] [Related]  

  • 7. Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial.
    Meszaros ZS; Abdul-Malak Y; Dimmock JA; Wang D; Ajagbe TO; Batki SL
    J Clin Psychopharmacol; 2013 Apr; 33(2):243-7. PubMed ID: 23422399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo.
    Garza D; Murphy M; Tseng LJ; Riordan HJ; Chatterjee A
    Biol Psychiatry; 2011 Jun; 69(11):1075-82. PubMed ID: 21295286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varenicline prevents affective and cognitive exacerbation during smoking abstinence in male patients with schizophrenia.
    Liu ME; Tsai SJ; Jeang SY; Peng SL; Wu SL; Chen MC; Tsai YL; Yang ST
    Psychiatry Res; 2011 Nov; 190(1):79-84. PubMed ID: 21636135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varenicline in smoking cessation.
    Tonstad S; Rollema H
    Expert Rev Respir Med; 2010 Jun; 4(3):291-9. PubMed ID: 20524911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness and safety of varenicline for smoking cessation].
    Christalla P; Dewenter M; El-Armouche A
    Dtsch Med Wochenschr; 2012 May; 137(18):940-4. PubMed ID: 22492478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.
    Hong LE; Thaker GK; McMahon RP; Summerfelt A; Rachbeisel J; Fuller RL; Wonodi I; Buchanan RW; Myers C; Heishman SJ; Yang J; Nye A
    Arch Gen Psychiatry; 2011 Dec; 68(12):1195-206. PubMed ID: 21810630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On oral medications, especially varenicline].
    Kurioka N
    Nihon Rinsho; 2013 Mar; 71(3):487-92. PubMed ID: 23631241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of nicotine dependence with Chantix (varenicline).
    Rankin KV; Jones DL
    Tex Dent J; 2011 May; 128(5):457-61. PubMed ID: 21834368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder.
    Smith RC; Lindenmayer JP; Davis JM; Cornwell J; Noth K; Gupta S; Sershen H; Lajtha A
    Schizophr Res; 2009 May; 110(1-3):149-55. PubMed ID: 19251401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varenicline efficacy and tolerability in a subject with schizophrenia.
    Fatemi SH
    Schizophr Res; 2008 Aug; 103(1-3):328-9. PubMed ID: 18572388
    [No Abstract]   [Full Text] [Related]  

  • 17. Adverse neuropsychiatric events associated with varenicline use in veterans: a case series.
    Cantrell M; Argo T; Haak L; Janney L
    Issues Ment Health Nurs; 2012 Oct; 33(10):665-9. PubMed ID: 23017042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis.
    Tonstad S; Davies S; Flammer M; Russ C; Hughes J
    Drug Saf; 2010 Apr; 33(4):289-301. PubMed ID: 20297861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varenicline-associated acute renal failure.
    Bird ML; Vesta KS
    Ann Pharmacother; 2008 Dec; 42(12):1908-11. PubMed ID: 18984856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summaries for patients. Does varenicline help people with depression quit smoking?
    Ann Intern Med; 2013 Sep; 159(6):I-36. PubMed ID: 24042380
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.